Author: Gorman, Declan M.; Lee, John; Payne, Colton D.; Woodruff, Trent M.; Clark, Richard J.
Title: Chemical synthesis and characterisation of the complement C5 inhibitory peptide zilucoplan Cord-id: 1buhuoeb Document date: 2021_1_4
ID: 1buhuoeb
Snippet: The complement component C5 inhibitory peptide zilucoplan is currently in phase III clinical trials for myasthenia gravis (MG). Despite being at an advanced stage of clinical development, there have been no published reports in the literature detailing its chemical synthesis. In this work, we describe an approach for the chemical synthesis of zilucoplan and validate that the synthesised compound blocks LPS-induced C5a production from human blood. ELECTRONIC SUPPLEMENTARY MATERIAL: The online ver
Document: The complement component C5 inhibitory peptide zilucoplan is currently in phase III clinical trials for myasthenia gravis (MG). Despite being at an advanced stage of clinical development, there have been no published reports in the literature detailing its chemical synthesis. In this work, we describe an approach for the chemical synthesis of zilucoplan and validate that the synthesised compound blocks LPS-induced C5a production from human blood. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00726-020-02921-5) contains supplementary material, which is available to authorized users.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date